Lleida.net covers 100% of its newest private purchase plan, in a transaction of more than 225,000 euros
September 24, 2024 02:00 ET
|
LLeida.net
Madrid, September 24th - The Spanish listed company Lleida.net (BME:LLN) (EPA:ALLN) (OTCQX:LLEIF) has successfully closed 100% of the “Lleida.net 2024 Private Purchase Plan”, launched by its CEO,...
Haffner Energy teams up with Bambbco, France’s leading bamboo provider, to diversify sustainable biomass procurement
September 24, 2024 02:00 ET
|
HAFFNER ENERGY
Haffner Energy teams up with Bambbco, France’s leading bamboo provider, to diversify sustainable biomass procurement Vitry-le-François, September 24, 2024, at 8:00 am (CEST) Haffner Energy and...
Sampo plc’s share buybacks 23 September 2024
September 24, 2024 01:30 ET
|
Sampo plc
Sampo plc, stock exchange release, 24 September 2024 at 8:30 am EEST Sampo plc’s share buybacks 23 September 2024 On 23 September 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22)...
BGHL (GBP): NAV(s)
September 24, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
BGHL (EUR): NAV(s)
September 24, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis
September 24, 2024 01:15 ET
|
Basilea Pharmaceutica AG, Allschwil
Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
Belships ASA: Key information relating to the cash dividend to be paid by Belships ASA
September 24, 2024 01:01 ET
|
Belships ASA
Oslo, 24 September 2024 The distribution will be made as an ordinary dividend Dividend amount: NOK 1.00 per share Declared currency: NOK Last day including right: 25 September 2024 Ex date: 26...
UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024
September 24, 2024 01:00 ET
|
Biogen Inc.
Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe systemic lupus erythematosus; Clinical improvements were observed among key secondary...
Nature Reviews Highlights Significant Successes of Antibiotic Collaboration and Calls for Sustainable R&D Funding Schemes
September 24, 2024 01:00 ET
|
BioVersys
BASEL, Switzerland, Sept. 24, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for...
Belships ASA: Extraordinary dividend payment
September 24, 2024 01:00 ET
|
Belships ASA
Oslo, 24 September 2024 The sale of the debt-free supramax vessels BELFRIEND and BELTIDE has been completed and the sale proceeds of USD 56.6m have been received. Due to the Company's strong...